Abilify MyCite Interactions
There are 721 drugs known to interact with Abilify MyCite (aripiprazole), along with 17 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 65 are major, 654 are moderate, and 2 are minor.
- View all 721 medications that may interact with Abilify MyCite
- View Abilify MyCite alcohol/food interactions (4)
- View Abilify MyCite disease interactions (17)
Most frequently checked interactions
View interaction reports for Abilify MyCite (aripiprazole) and the medicines listed below.
- acetaminophen
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall XR (amphetamine / dextroamphetamine)
- Adempas (riociguat)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Afinitor Disperz (everolimus)
- Afstyla (antihemophilic factor)
- amlodipine
- atorvastatin
- clonazepam
- Depakote (divalproex sodium)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydroxyzine
- Invega Trinza (paliperidone)
- Lamictal (lamotrigine)
- lamotrigine
- lansoprazole
- Latuda (lurasidone)
- lisinopril
- paliperidone
- Topamax (topiramate)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vraylar (cariprazine)
- Zyprexa Zydis (olanzapine)
Abilify MyCite alcohol/food interactions
There are 4 alcohol/food interactions with Abilify MyCite (aripiprazole).
Abilify MyCite disease interactions
There are 17 disease interactions with Abilify MyCite (aripiprazole) which include:
- suicidality
- dementia
- acute alcohol intoxication
- CNS depression
- NMS
- aspiration
- seizure
- hematologic abnormalities
- hyperglycemia/diabetes
- hypotension
- lipid alterations
- weight gain
- anticholinergic effects
- hyperprolactinemia
- liver disease
- parkinsonism
- tardive dyskinesia
More about Abilify MyCite (aripiprazole)
- Abilify MyCite consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.